These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16356118)

  • 1. Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications.
    Obrosova IG
    Antioxid Redox Signal; 2005; 7(11-12):1543-52. PubMed ID: 16356118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Aldose Reductase in Polyol Pathway: An Emerging Pharmacological Target in Diabetic Complications and Associated Morbidities.
    Gupta JK
    Curr Pharm Biotechnol; 2024; 25(9):1073-1081. PubMed ID: 37649296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy.
    Obrosova IG; Julius UA
    Curr Vasc Pharmacol; 2005 Jul; 3(3):267-83. PubMed ID: 16026323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges.
    ElGamal H; Munusamy S
    Protein Pept Lett; 2017; 24(1):71-77. PubMed ID: 27894247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does glucose generate oxidative stress in peripheral nerve?
    Obrosova IG
    Int Rev Neurobiol; 2002; 50():3-35. PubMed ID: 12198815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage.
    Ho EC; Lam KS; Chen YS; Yip JC; Arvindakshan M; Yamagishi S; Yagihashi S; Oates PJ; Ellery CA; Chung SS; Chung SK
    Diabetes; 2006 Jul; 55(7):1946-53. PubMed ID: 16804062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase.
    Changolkar AK; Hypolite JA; Disanto M; Oates PJ; Wein AJ; Chacko S
    J Urol; 2005 Jan; 173(1):309-13. PubMed ID: 15592102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.
    Obrosova IG; Minchenko AG; Frank RN; Seigel GM; Zsengeller Z; Pacher P; Stevens MJ; Szabó C
    Int J Mol Med; 2004 Jul; 14(1):55-64. PubMed ID: 15202016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pathogenesis of diabetic and hepatic neuropathies].
    Winkler G; Kempler P
    Orv Hetil; 2001 Nov; 142(45):2459-67. PubMed ID: 11778353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts and insights on pathogenesis and treatment of diabetic complications: polyol pathway and its inhibition.
    Hotta N
    Nagoya J Med Sci; 1997 Nov; 60(3-4):89-100. PubMed ID: 9481088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications.
    Chiu J; Xu BY; Chen S; Feng B; Chakrabarti S
    Can J Physiol Pharmacol; 2008 Jun; 86(6):365-72. PubMed ID: 18516100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic neuropathies. Metabolism of sorbitol in sciatic nerve tissue in streptozotocin diabetes].
    Kryvko IuIa; Kozyts'kyĭ ZIa; Serhiienko OO; Kuchmerovs'ka TM; Velykyĭ MM
    Ukr Biokhim Zh (1999); 2001; 73(5):69-74. PubMed ID: 12035507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of polyol pathways in formation of diabetic cataracts].
    Sabasiński K; Andrzejewska-Buczko J
    Klin Oczna; 1997; 99(6):401-4. PubMed ID: 9685789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemia, polyol metabolism, and complications of diabetes mellitus.
    Gabbay KH
    Annu Rev Med; 1975; 26():521-36. PubMed ID: 238458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aldose reductase controversy.
    Frank RN
    Diabetes; 1994 Feb; 43(2):169-72. PubMed ID: 8288039
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sorbitol, phosphoinositides and Na K-ATPase in the pathogenesis of diabetic complications].
    Greene DA; Sima AA; Lattimer SA
    Journ Annu Diabetol Hotel Dieu; 1988; ():105-17. PubMed ID: 2845181
    [No Abstract]   [Full Text] [Related]  

  • 19. Aldose reductase and its inhibition in the control of diabetic complications.
    Narayanan S
    Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
    Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.